Cargando…

N(6)-Methyladenosine: A Novel RNA Imprint in Human Cancer

N(6)-Methyladenosine (m(6)A), a pervasive posttranscriptional modification which is reversible, has been among hotspot issues in the past several years. The balance of intracellular m(6)A levels is dynamically maintained by methyltransferase complex and demethylases. Meanwhile, m(6)A reader proteins...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Sihui, Li, Xi, Liu, Shiyun, Yang, Rui, Liu, Xiangnan, Wu, Sufang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930912/ https://www.ncbi.nlm.nih.gov/pubmed/31921664 http://dx.doi.org/10.3389/fonc.2019.01407

Ejemplares similares

Landscape of N(6)-Methyladenosine Modification Patterns in Human Ameloblastoma
por: Niu, Xing, et al.
Publicado: (2020)

RNA N (6)-Methyladenosine in Cancer Metastasis: Roles, Mechanisms, and Applications
por: Dang, Qin, et al.
Publicado: (2021)

N6-Methyladenosine-Sculpted Regulatory Landscape of Noncoding RNA
por: Zhang, Zhongyuan, et al.
Publicado: (2021)

Mechanisms of RNA N(6)-Methyladenosine in Hepatocellular Carcinoma: From the Perspectives of Etiology
por: Lu, Jiahua, et al.
Publicado: (2020)

The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer
por: Hu, Xiaoge, et al.
Publicado: (2022)

Research Progress on Long Noncoding RNAs and N6-Methyladenosine in Hepatocellular Carcinoma
por: Zhang, Wenjie, et al.
Publicado: (2022)

N6-Methyladenosine Regulators Promote Malignant Progression of Gastric Adenocarcinoma
por: Zhao, Yibin, et al.
Publicado: (2022)

RNA N6-Methyladenosine Regulator-Mediated Methylation Modifications Pattern and Immune Infiltration Features in Glioblastoma
por: Pan, Yimin, et al.
Publicado: (2021)

BTG2 suppresses renal cell carcinoma progression through N6-methyladenosine
por: Qi, Fuming, et al.
Publicado: (2022)

RNA Modification of N6-Methyladenosine Predicts Immune Phenotypes and Therapeutic Opportunities in Kidney Renal Clear Cell Carcinoma
por: Li, Huihuang, et al.
Publicado: (2021)

Main N6-Methyladenosine Readers: YTH Family Proteins in Cancers
por: Dai, Xin-Yuan, et al.
Publicado: (2021)

Transcriptome-Wide Map of N(6)-Methyladenosine Methylome Profiling in Human Bladder Cancer
por: Li, Aolin, et al.
Publicado: (2021)

The regulatory role of N6-methyladenosine RNA modification in gastric cancer: Molecular mechanisms and potential therapeutic targets
por: Li, Gaofeng, et al.
Publicado: (2022)

Regulatory Role of N6-methyladenosine (m(6)A) Modification in Osteosarcoma
por: Zhang, Yujie, et al.
Publicado: (2021)

Mechanism of RNA modification N6-methyladenosine in human cancer
por: Zhou, Zijian, et al.
Publicado: (2020)

N(6)-Methyladenosine RNA Demethylase FTO Promotes Gastric Cancer Metastasis by Down-Regulating the m6A Methylation of ITGB1
por: Wang, Duo, et al.
Publicado: (2021)

High Expression of PAMR1 Predicts Favorable Prognosis and Inhibits Proliferation, Invasion, and Migration in Cervical Cancer
por: Yang, Rui, et al.
Publicado: (2021)

Role of N6-Methyladenosine (m(6)A) Methylation Regulators in Hepatocellular Carcinoma
por: Qu, Nanfang, et al.
Publicado: (2021)

N6-Methyladenosine Modification of PTTG3P Contributes to Colorectal Cancer Proliferation via YAP1
por: Zheng, Yang, et al.
Publicado: (2021)

Molecular Characterization and Clinical Relevance of N(6)-Methyladenosine Regulators in Metastatic Prostate Cancer
por: Liu, Qiwei, et al.
Publicado: (2022)

The emerging therapeutic target of dynamic and reversible N6-methyladenosine modification during cancer development
por: Liu, Shougeng, et al.
Publicado: (2022)

IGF2BP3 promotes progression of gallbladder carcinoma by stabilizing KLK5 mRNA in N(6)-methyladenosine-dependent binding
por: Zhang, Junzhe, et al.
Publicado: (2022)

Identification of a N6-Methyladenosine (m6A)-Related lncRNA Signature for Predicting the Prognosis and Immune Landscape of Lung Squamous Cell Carcinoma
por: Weng, Chengyin, et al.
Publicado: (2021)

The Interaction Between N(6)-Methyladenosine Modification and Non-Coding RNAs in Gastrointestinal Tract Cancers
por: Yao, Lin, et al.
Publicado: (2022)

Identification of N6-Methyladenosine-Related lncRNAs as a Prognostic Signature in Glioma
por: Chen, Yujia, et al.
Publicado: (2022)

Identification and Validation of N6-Methyladenosine-Related Biomarkers for Bladder Cancer: Implications for Immunotherapy
por: Deng, Hongyu, et al.
Publicado: (2022)

Effects of N(6)-Methyladenosine Modification on Cancer Progression: Molecular Mechanisms and Cancer Therapy
por: Zhu, Yong-fu, et al.
Publicado: (2022)

Regulation of Gene Expression Associated With the N6-Methyladenosine (m6A) Enzyme System and Its Significance in Cancer
por: Tian, Shuoran, et al.
Publicado: (2021)

The m6A Methyltransferase METTL14-Mediated N6-Methyladenosine Modification of PTEN mRNA Inhibits Tumor Growth and Metastasis in Stomach Adenocarcinoma
por: Yao, Qi, et al.
Publicado: (2021)

N6-Methyladenosine RNA Methylation in Cardiovascular Diseases
por: Liu, Chi, et al.
Publicado: (2022)

Identification of N6-Methyladenosine-Related LncRNAs for Predicting Overall Survival and Clustering of a Potentially Novel Molecular Subtype of Breast Cancer
por: Zhong, Xiaoxiao, et al.
Publicado: (2021)

RNA N(6)-Methyladenosine Modifications and the Immune Response
por: Wang, Ya-Nan, et al.
Publicado: (2020)

N(6)-Methyladenosine (m(6)A): A Promising New Molecular Target in Acute Myeloid Leukemia
por: Ianniello, Zaira, et al.
Publicado: (2019)

The Roles of N(6)-Methyladenosine in Human Diseases
por: An, Shanshan, et al.
Publicado: (2019)

N(6)‐methyladenosine Steers RNA Metabolism and Regulation in Cancer
por: Dong, Shenghua, et al.
Publicado: (2021)

N(6)-Methyladenosine Regulators and Related LncRNAs Are Potential to be Prognostic Markers for Uveal Melanoma and Indicators of Tumor Microenvironment Remodeling
por: Liu, Zhicheng, et al.
Publicado: (2021)

Establishment of Prognostic Signatures of N6-Methyladenosine-Related lncRNAs and Their Potential Functions in Hepatocellular Carcinoma Patients
por: Wu, Xianbin, et al.
Publicado: (2022)

Biological function and research progress of N (6)-methyladenosine binding protein heterogeneous nuclear ribonucleoprotein A2B1 in human cancers
por: Wu, Yue, et al.
Publicado: (2023)

Analysis of N6-Methyladenosine Methyltransferase Reveals METTL14 and ZC3H13 as Tumor Suppressor Genes in Breast Cancer
por: Gong, Peng-Ju, et al.
Publicado: (2020)

N(6)-Methyladenosine: A Potential Breakthrough for Human Cancer
por: Liu, Lina, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mcrpod5927rs5jsobotq3e9t55